The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 11,601 | 21,153 |
| Net amortization on securities available for sale | 1,241 | 1,394 |
| Net gain on sales of securities available for sale | 59 | 475 |
| Provision for credit losses on loans | 900 | 3,500 |
| Credit for credit losses on off-balance sheet exposures | 200 | - |
| Depreciation of premises and equipment | 625 | 1,256 |
| Amortization of other intangible assets | 230 | 460 |
| Amortization of right-of use asset | 139 | 280 |
| Cash surrender value of bank-owned life insurance | 439 | 767 |
| Amortization of subordinated debt issuance costs | 37 | 171 |
| Stock-based compensation | 1,079 | 2,039 |
| Deferred income taxes | -1,140 | -1,561 |
| Accrued interest receivable and other assets | 2,065 | -833 |
| Accrued interest payable and other liabilities | -491 | -14,036 |
| Net cash provided by operating activities | 9,376 | 11,459 |
| Decrease in bank-owned certificates of deposit | 239 | 480 |
| Proceeds from sales of securities available for sale | 5,112 | 59,595 |
| Proceeds from maturities, paydowns, payups and calls of securities available for sale | 58,059 | 50,531 |
| Purchases of securities available for sale | 130,469 | 73,642 |
| Net increase in loans | 68,193 | 276,653 |
| Net decrease (increase) in fhlb stock | -99 | 2,175 |
| Purchases of premises and equipment | 1,601 | 1,702 |
| Purchase of bank-owned life insurance | 4,630 | - |
| Redemption of bank-owned life insurance | 4,361 | - |
| Net cash used in investing activities | -137,023 | -243,566 |
| Net increase in deposits | 56,022 | 149,975 |
| Principal payments on notes payable | 13,750 | - |
| Proceeds from fhlb advances | 303,000 | 633,500 |
| Principal payments on fhlb advances | 303,000 | 588,500 |
| Issuance of subordinated debt, net of issuance costs | -138 | 78,828 |
| Redemption of subordinated debt. net of issuance costs | 0 | 49,980 |
| Preferred stock dividends paid | 1,013 | 2,027 |
| Stock options exercised | 882 | 365 |
| Stock repurchases | 0 | 2,191 |
| Shares repurchased for tax withholdings upon vesting of restricted stock-based awards | 3 | 128 |
| Shares repurchased for tax withholdings upon exercise of stock options | 30 | - |
| Net cash provided by financing activities | 41,970 | 219,842 |
| Net change in cash and cash equivalents | -85,677 | -12,265 |
| Cash and cash equivalents at beginning of period | 229,760 | - |
| Cash and cash equivalents at end of period | 131,818 | - |
Bridgewater Bancshares Inc (BWB)
Bridgewater Bancshares Inc (BWB)